13F Data
13F filer · CIK 1802630

Soleus Capital Management, L.P.

GREENWICH, CT · filing since Q4 2019 · last filing Aug 11, 2026
Reported value
$2.9B
+$432.8M vs prior
Positions
97
New / sold out
22 / 18
Added / reduced
25 / 41
Turnover
29.0%
buys $777.5M · sells $927.7M
Top-10 weight
48.9%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedINSULET CORP+486,500+86.5%+$74.1M
AddedRIGEL PHARMACEUTICALS INC+1,833,504+18335.0%+$71.7M
AddedINSPIRE MED SYS INC+1,355,137+235.1%+$60.5M
NewERASCA INC+2,700,000–+$49.5M
AddedCELCUITY INC+419,940+32.7%+$43.9M
NewPARABILIS MEDICINES INC+1,465,070–+$40.1M
NewLEGEND BIOTECH CORP+1,205,000–+$34.8M
NewUNITEDHEALTH GROUP INC+80,000–+$33.3M
NewPALISADE BIO INC+13,063,687–+$27.3M
NewSUPERNUS PHARMACEUTICALS+520,000–+$24.2M
37 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedTWIST BIOSCIENCE CORP-1,122,000-91.5%$-115.4M
ReducedKRYSTAL BIOTECH INC-213,833-18.5%$-79.5M
ReducedTG THERAPEUTICS INC-1,101,424-27.3%$-60.5M
ReducedPRAXIS PRECISION MEDICINES I-153,000-46.3%$-51.2M
ReducedALKERMES PLC-941,612-47.8%$-49.3M
ReducedVERICEL CORP-1,089,927-42.8%$-48.5M
ReducedEDGEWISE THERAPEUTICS INC-999,026-68.9%$-40.6M
ReducedMIRUM PHARMACEUTICALS INC-325,306-81.3%$-38.1M
ReducedNATERA INC-118,000-99.2%$-32.0M
ReducedALNYLAM PHARMACEUTICALS INC-98,600-74.9%$-29.7M
49 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2019: $103.7MQ1 2020: $85.9MQ2 2020: $175.4MQ3 2020: $188.6MQ4 2020: $757.9MQ1 2021: $555.0MQ2 2021: $650.3MQ3 2021: $641.7MQ4 2021: $998.8MQ1 2022: $775.1MQ2 2022: $641.0MQ3 2022: $736.0MQ4 2022: $697.1MQ1 2023: $965.7MQ2 2023: $899.5MQ3 2023: $1.1BQ4 2023: $901.2MQ1 2024: $1.3BQ2 2024: $1.1BQ3 2024: $1.3BQ4 2024: $1.6BQ1 2025: $1.4BQ2 2025: $1.5BQ3 2025: $2.0BQ4 2025: $2.7BQ1 2026: $2.5BQ2 2026: $2.9B
Q4 2019Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1KRYSTAL BIOTECH INCCOM939,254$349.1M12.03%
2CELCUITY INCCOM1,704,318$178.3M6.14%
3TG THERAPEUTICS INCCOM2,927,895$160.9M5.54%
4INSULET CORPCOM1,049,000$159.7M5.50%
5NOVOCURE LTDORD SHS9,913,401$150.2M5.18%
6UNITED THERAPEUTICS CORP DELCOM225,587$122.2M4.21%
7INSPIRE MED SYS INCCOM1,931,436$86.2M2.97%
8RIGEL PHARMACEUTICALS INCCOM1,843,504$72.1M2.49%
9ANI PHARMACEUTICALS INCCOM867,760$71.8M2.48%
10BETA BIONICS INCCOM4,393,714$68.8M2.37%
87 more rows. Subscribe for $29/month to see every row, download the data and use the API.